Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of thiazolidinedione treatment on progression of subclinical atherosclerosis in premenopausal women at high risk for type 2 diabetes.
Xiang AH, Peters RK, Kjos SL, Ochoa C, Marroquin A, Goico J, Tan S, Wang C, Azen SP, Liu CR, Liu CH, Hodis HN, Buchanan TA. Xiang AH, et al. Among authors: goico j. J Clin Endocrinol Metab. 2005 Apr;90(4):1986-91. doi: 10.1210/jc.2004-1685. Epub 2004 Dec 28. J Clin Endocrinol Metab. 2005. PMID: 15623809 Clinical Trial.
Effect of pioglitazone on progression of subclinical atherosclerosis in non-diabetic premenopausal Hispanic women with prior gestational diabetes.
Xiang AH, Hodis HN, Kawakubo M, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Liu CR, Liu CH, Buchanan TA. Xiang AH, et al. Among authors: goico j. Atherosclerosis. 2008 Jul;199(1):207-14. doi: 10.1016/j.atherosclerosis.2007.10.016. Epub 2007 Dec 4. Atherosclerosis. 2008. PMID: 18054942 Free PMC article. Clinical Trial.
Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of Diabetes (TRIPOD) study.
Snitker S, Watanabe RM, Ani I, Xiang AH, Marroquin A, Ochoa C, Goico J, Shuldiner AR, Buchanan TA; Troglitazone in Prevention of Diabetes (TRIPOD) study. Snitker S, et al. Among authors: goico j. Diabetes Care. 2004 Jun;27(6):1365-8. doi: 10.2337/diacare.27.6.1365. Diabetes Care. 2004. PMID: 15161789 Free PMC article. Clinical Trial.